Targeting the Choroid Plexus-CSF-Brain Nexus Using Peptides Identified by Phage Display

Methods in Molecular Biology

Volumn 686, Issue , 2011, Pages 483-498

  Baird, Andrew ^a   Eliceiri, Brian P ^a   Gonzalez, Ana Maria ^b   Johanson, Conrad E ^c   Leadbeater, Wendy ^b   Stopa, Edward G ^c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^c BROWN UNIVERSITY   (United States)

Author keywords

Blood brain barrier; Blood CSF barrier; Choroid epithelial cells; Choroid plexus; CNS targeting; Combinatorial biology; Drug translocation; Ex vivo biopanning; Library screening; Ligand internalization; Phage display; Screening

Indexed keywords

PEPTIDE; PEPTIDE LIBRARY;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BLOOD BRAIN BARRIER; BRAIN; CEREBROSPINAL FLUID; CHEMISTRY; CHOROID PLEXUS; DRUG DELIVERY SYSTEM; DRUG EFFECT; METABOLISM; MOUSE; PHYSIOLOGY; VASCULARIZATION;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CEREBROSPINAL FLUID; CHOROID PLEXUS; DRUG DELIVERY SYSTEMS; MICE; MICE, INBRED BALB C; PEPTIDE LIBRARY; PEPTIDES;

MLCS; MLOWN;

EID: 79957764764     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-60761-938-3_25     Document Type: Chapter

References (52)

1. Smith GP (1985) Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 228:1315–1317
2. Barbas CF (2001) Phage display: a laboratory manual. Cold Spring Harbor: Cold Spring Harbor Laboratory
3. Pasqualini R, Arap W, McDonald DM (2002) Probing the structural and molecular diversity of tumor vasculature. Trends Mol Med 8:563–571
4. Larocca D, Baird A (2001) Receptor-mediated gene transfer by phage-display vectors: applications in functional genomics and gene therapy. Drug Discov Today 6:793–801
5. Larocca D, Burg MA, Jensen-Pergakes K, Ravey EP, Gonzalez AM, Baird A (2002) Evolving phage vectors for cell targeted gene delivery. Curr Pharm Biotechnol 3:45–57
6. Larocca D, Jensen-Pergakes K, Burg MA, Baird A (2001) Receptor-targeted gene delivery using multivalent phagemid particles. Mol Ther 3:476–484
7. Larocca D, Jensen-Pergakes K, Burg MA, Baird A (2002) Gene transfer using targeted filamentous bacteriophage. Methods Mol Bio185:393–401
8. Larocca D, Kassner PD, Witte A, Ladner RC, Pierce GF, Baird A (1999) Gene transfer to mammalian cells using genetically targeted filamentous bacteriophage. Faseb J 13:727–734
9. Larocca D, Witte A, Johnson W, Pierce GF, Baird A (1998) Targeting bacteriophage to mammalian cell surface receptors for gene delivery. Hum Gene Ther 9:2393–2399
10. Hart SL, Knight AM, Harbottle RP, Mistry A, Hunger HD, Cutler DF, Williamson R, Coutelle C (1994) Cell binding and internalization by filamentous phage displaying a cyclic Arg-Gly-Asp-containing peptide. J Biol Chem 269:12468–12474
11. Ivanenkov VV, Menon AG (2000) Peptide-mediated transcytosis of phage display vectors in MDCK cells. Biochem Biophys Res Commun 276:251–257
12. Merril CR, Biswas B, Carlton R, Jensen NC, Creed GJ, Zullo S, Adhya S (1996) Long-circulating bacteriophage as antibacterial agents. Proc Natl Acad Sci U S A 93: 3188–3192
13. Muruganandam A, Tanha J, Narang S, Stanimirovic D (2002) Selection of phage-displayed llama single-domain antibodies that transmigrate across human blood-brain barrier endothelium. Faseb J 16:240–242
14. Pasqualini R (1999) Vascular targeting with phage peptide libraries. Q J Nucl Med 43:159–162
15. Pasqualini R, Ruoslahti E (1996) Organ targeting in vivo using phage display peptide libraries. Nature 380:364–366
16. Pasqualini R, Ruoslahti E (1996) Searching for a molecular address in the brain. Mol Psychiatry 1:421–422
17. Pasqualini R, Ruoslahti E (1996) Tissue targeting with phage peptide libraries. Mol Psychiatry 1:423
18. Petrenko VA, Smith GP (2000) Phage from landscape libraries as substitute antibodies. Protein Eng 13:589–592
19. Petrenko VA, Smith GP, Gong X, Quinn T (1996) A library of organic landscapes on filamentous phage. Protein Eng 9:797–801
20. Poul MA, Marks JD (1999) Targeted gene delivery to mammalian cells by filamentous bacteriophage. J Mol Biol 288:203–211
21. Rajotte D, Arap W, Hagedorn M, Koivunen E, Pasqualini R, Ruoslahti E (1998) Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display. J Clin Invest 102:430–437
22. Sokoloff AV, Bock I, Zhang G, Sebestyen MG, Wolff JA (2000) The interactions of peptides with the innate immune system studied with use of T7 phage peptide display. Mol Ther 2:131–139
23. Yip YL, Hawkins NJ, Smith G, Ward RL (1999) Biodistribution of filamentous phage-Fab in nude mice. J Immunol Methods 225:171–178
24. Koivunen E, Arap W, Valtanen H, Rainisalo A, Medina OP, Heikkila P, Kantor C, Gahmberg CG, Salo T, Konttinen YT, Sorsa T, Ruoslahti E, Pasqualini R (1999) Tumor targeting with a selective gelatinase inhibitor. Nat Biotechnol 17:768–774
25. Koivunen E, Restel BH, Rajotte D, Lahdenranta J, Hagedorn M, Arap W, Pasqualini R (1999) Integrin-binding peptides derived from phage display libraries. Methods Mol Biol 129:3–17
26. Trepel M, Arap W, Pasqualini R (2000) Exploring vascular heterogeneity for gene therapy targeting. Gene Ther 7:2059–2060
27. Trepel M, Grifman M, Weitzman MD, Pasqualini R (2000) Molecular adaptors for vascular-targeted adenoviral gene delivery. Hum Gene Ther 11:1971–1981
28. Burg MA, Jensen-Pergakes K, Gonzalez AM, Ravey P, Baird A, Larocca D (2002) Enhanced phagemid particle gene transfer in camptothe-cin-treated carcinoma cells. Cancer Res 62: 977–981
29. Burg M, Ravey EP, Gonzales M, Amburn E, Faix PH, Baird A, Larocca D (2004) Selection of internalizing ligand-display phage using rolling circle amplification for phage recovery. DNA Cell Biol 23:457–462
30. Kassner PD, Burg MA, Baird A, Larocca D (1999) Genetic selection of phage engineered for receptor-mediated gene transfer to mammalian cells. Biochem Biophys Res Commun 264:921–928
31. Chodobski A, Szmydynger-Chodobska J (2001) Choroid plexus: target for polypeptides and site of their synthesis. Microsc Res Tech 52:65–82
32. Emerich DF, Vasconcellos AV, Elliott RB, Skinner SJ, Borlongan CV (2004) The choroid plexus: function, pathology and therapeutic potential of its transplantation. Expert Opin Biol Ther 4:1191–1201
33. Ghersi-Egea JF, Strazielle N (2002) Choroid plexus transporters for drugs and other xenobiotics. J Drug Target 10:353–357
34. Johanson CE, Duncan JA, Stopa EG, Baird A (2005) Enhanced prospects for drug delivery and brain targeting by the choroid plexus-CSF route. Pharm Res 22:1011–1037
35. Silverberg GD, Huhn S, Jaffe RA, Chang SD, Saul T, Heit G, Von Essen A, Rubenstein E (2002) Downregulation of cerebrospinal fluid production in patients with chronic hydrocephalus. J Neurosurg 97:1271–1275
36. Spector R, Johanson C (2006) Micronutrient and urate transport in choroid plexus and kidney: implications for drug therapy. Pharm Res 23:2515–2524
37. Carro E, Spuch C, Trejo JL, Antequera D, Torres-Aleman I (2005) Choroid plexus meg-alin is involved in neuroprotection by serum insulin-like growth factor I. J Neurosci 25:10884–10893
38. Hakvoort A, Haselbach M, Galla HJ (1998) Active transport properties of porcine choroid plexus cells in culture. Brain Res 795:247–256
39. Johanson CE, Gonzalez AM, Stopa EG (2001) Water-imbalance-induced expression of FGF-2 in fluid-regulatory centers: choroid plexus and neurohypophysis. Eur J Pediatr Surg 11 Suppl 1:S37–38
40. Liao CW, Fan CK, Kao TC, Ji DD, Su KE, Lin YH, Cho WL (2008) Brain injury-associated biomarkers of TGF-beta1, S100B, GFAP, NF-L, tTG, AbetaPP, and tau were concomi-tantly enhanced and the UPS was impaired during acute brain injury caused by Toxocara canis in mice. BMC Infect Dis 8:84
41. Parandoosh Z, Johanson CE (1982) Ontogeny of blood-brain barrier permeability to, and cerebrospinal fluid sink action on, [14C] urea. Am J Physiol 243:R400–407
42. Schreiber G (2002) The evolution of transthyretin synthesis in the choroid plexus. Clin Chem Lab Med 40:1200–1210
43. Borlongan CV, Thanos CG, Skinner SJ, Geaney M, Emerich DF (2008) Transplants of encapsulated rat choroid plexus cells exert neuroprotection in a rodent model of Huntington’s disease. Cell Transplant 16:987–992
44. Emerich DF, Skinner SJ, Borlongan CV, Thanos CG (2005) A role of the choroid plexus in transplantation therapy. Cell Transplant 14:715–725
45. Johanson CE, Szmydynger-Chodobska J, Chodobski A, Baird A, McMillan P, Stopa EG (1999) Altered formation and bulk absorption of cerebrospinal fluid in FGF-2-induced hydrocephalus. Am J Physiol 277:R263–271
46. Logan A, Frautschy SA, Gonzalez AM, Sporn MB, Baird A (1992) Enhanced expression of transforming growth factor beta 1 in the rat brain after a localized cerebral injury. Brain Res 587:216–225
47. Stopa EG, Berzin TM, Kim S, Song P, Kuo-LeBlanc V, Rodriguez-Wolf M, Baird A, Johanson CE (2001) Human choroid plexus growth factors: What are the implications for CSF dynamics in Alzheimer’s disease? Exp Neurol 167:40–47
48. Strazielle N, Ghersi-Egea JF (1999) Demonstration of a coupled metabolism-efflux process at the choroid plexus as a mechanism of brain protection toward xenobiotics. J Neurosci 19:6275–6289
49. Vercellino M, Votta B, Condello C, Piacentino C, Romagnolo A, Merola A, Capello E, Mancardi GL, Mutani R, Giordana MT, Cavalla P (2008) Involvement of the choroid plexus in multiple sclerosis autoimmune inflammation: a neuropathological study. J Neuroimmunol 199:133–141
50. Saggio I, Gloaguen I, Laufer R (1995) Functional phage display of ciliary neurotrophic factor. Gene 152:35–39
51. Buchli PJ, Wu Z, Ciardelli TL (1997) The functional display of interleukin-2 on filamentous phage. Arch Biochem Biophys 339: 79–84
52. Hosoya K, Hori S, Ohtsuki S, Terasaki T (2004) A new in vitro model for blood-cerebrospinal fluid barrier transport studies: an immortalized choroid plexus epithelial cell line derived from the tsA58 SV40 large T-antigen gene transgenic rat. Adv Drug Deliv Rev 56:1875–1885